Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 8.29% vs -31.32% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 1,290.91% vs -96.46% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 10.77% vs -73.44% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -75.00% vs 33.33% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Sichuan Goldstone Asia Pharmaceutical, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 8.29% vs -31.32% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -7.63% vs 21.42% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 1,290.91% vs -96.46% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 70.95% vs 198.35% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 10.77% vs -73.44% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -35.43% vs 696.43% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -75.00% vs 33.33% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -66.67% vs -25.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






